Welcome to our dedicated page for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ SEC filings (Ticker: ZION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s regulatory disclosures and financial reporting.
ZIONS BANCORPORATION, NATIONAL ASSOCIATION filed a Form 13F reporting its institutional holdings, listing 1,550 reported positions with a total market value of $1,551,100,385. The filing is signed by Joe Edmiston Jr. and dated 05-08-2026.
ZIONS BANCORPORATION Controller Robert Ryan Richards exercised stock options to acquire 2,004 shares of Common Stock at $52.90 per share. The transaction reflects a derivative exercise, not an open-market purchase or sale. Following the exercise, he directly holds 36,899 Common Stock shares. The exercised award was a stock option with a graded vesting schedule, where the date each portion became exercisable varied by vesting tranche, and this particular option position is now fully exercised with no remaining derivative balance reported.
Zions Bancorporation, N.A. delivered stronger first-quarter 2026 results, with diluted EPS rising to $1.56 from $1.13 a year earlier. Net interest income increased 6% to $662 million and net interest margin improved to 3.27%, helped by lower deposit and borrowing costs and a better asset mix.
Credit quality remained solid: the allowance for credit losses was $713 million, or 1.16% of total loans and leases, while nonperforming assets fell to $292 million, or 0.48%. Classified loans declined slightly to $2.3 billion, reflecting lower commercial real estate risk.
Total loans and leases grew to $61.3 billion and deposits to $76.9 billion, keeping the loan-to-deposit ratio at 80%. Available liquidity reached $46.9 billion, exceeding estimated uninsured deposits by a wide margin. The efficiency ratio improved to 65.0% as revenue growth outpaced expense increases.
ZIONS BANCORPORATION Executive Vice President Jennifer Anne Smith sold 550 shares of Common Stock in an open-market transaction at $62.96 per share. After this sale, she directly holds 6,527.407 shares. This appears as a relatively small, routine disposition compared with her remaining stake.
Zions Bancorporation, N.A. reported that it sold 460,153 Class B-1 shares of Visa Inc. on May 4, 2026. The sale generated aggregate proceeds of $215 million, producing a pre-tax gain of approximately the same amount. This gain will be recognized in the bank’s results for the second quarter of 2026, adding a sizable one-time boost to earnings for that period.
Zions Bancorporation, National Association reported the results of its annual shareholder meeting held on May 1, 2026. Shareholders elected 11 directors to one-year terms, with each nominee receiving over 104 million votes in favor.
They also ratified Ernst & Young LLP as independent auditor for 2026 with 120,123,130 votes for, approved on a nonbinding advisory basis 2025 executive compensation with 103,158,563 votes for, and rejected a shareholder proposal requesting a report on risks of misalignment between policies and customer base.
Lee Vivian S reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Vivian S. Lee received a grant of 2,055 Deferred Comp units tied to common stock at an economic value of $63.26 per unit. These phantom stock units are settled in cash upon death or retirement, bringing Lee’s total deferred units to 29,129.717.
CRITTENDEN GARY L reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Gary L. Crittenden received a compensation award of 2,055 deferred compensation units tied to the company’s common stock. The award was valued at $63.26 per unit and increases his directly held deferred comp balance to 31,748.67 units.
Each unit is economically equivalent to one share of common stock but is a phantom stock unit settled in cash rather than stock. The units are payable in cash upon the earlier of his death or retirement, making this a non‑market, cash‑settled compensation grant rather than an open‑market share purchase.
Murphy Edward F reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Edward F. Murphy received a grant of 2,055 shares of Common Stock as compensation. The shares were awarded at a value of $63.26 per share. Following this grant, Murphy directly holds a total of 43,250.678 Zions Bancorporation shares.
Skonnard Aaron reported acquisition or exercise transactions in this Form 4 filing.
Director Aaron Skonnard received a grant of deferred compensation units linked to Zions Bancorporation common stock value. The award covers 2,055 units at a reference value of $63.26 per unit, bringing his deferred comp balance to about 39,449.911 units.
Each unit is economically equivalent to one share of common stock, but the phantom stock units are settled in cash rather than actual shares. Payment occurs upon the earlier of death or retirement, making this a routine, long-term compensation grant rather than an open-market stock purchase or sale.